Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin + Paclitaxel in Advanced Breast Cancer
NCT03072992Phase 2Completed
- Sponsor
- National Center of Oncology
- Start
- Mar 2017
- Primary completion
- Nov 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of curcumin in breast cancer, sponsored by National Center of Oncology. Started Mar 2017; status: completed.
02
Drugs
curcumin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03072992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03072992.